1DeSmedt T, Raedt R, Vonck K, et aL Levetiracetam : part H the clinical profile of a novel anticonvulsant drug[ J ]. CNS Drug Rev, 2007,13 (1) :57 -78.
2Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A( SV 2A) in human brain and in CHO cells expressing the human recombinant protein[ J]. Eur J Pharmaco1,2006,536 ( 1-2 ) : 102-108.
3Rigo J M, Hans G, Nguyen L, et ul. The antiepileptic drug levetiracetam reverses the inhibition by negative allosterie modulators of GABA and glycinegated currents [ J]. BR J Phatmacol, 2002,136 (5) : 659-672.
4Carunchio J, Pieri M, Ciotti M T, et al. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam [ J ]. Epilepsia,2007,48 (4) : 654-662.
3Aldenkamp AP,de Krom M,Reijs R.Newer an tipe ileptic drugs and cognitive issuse.Epilepsia,2003,44(suppl4):S21-S29.
4Lagae L.Cognitive side effects of anti-epileptic drugs Therelevance in childhood epilepsy.Seizure,2006,15:235-241.
5Piazzini A,Chifari R,Canevini MP,et al.Levetiracetam:an improvement of attention and of oral fluency in patients with partial epilepsy.Epilepsy Res,2006,68:181.
